提尔泽帕提德通过对Nrf2/Keap1通路的调节来改善2型糖尿病相关的男性生殖功能障碍
1Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Saudi Arabia, P.O. Box 400, Al-Ahsa 31982, Saudi Arabia.
Toxicology research
|February 27, 2026
概括
蒂尔泽帕提德通过增强新陈代谢控制和抗氧化剂防御,显著改善了糖尿病大鼠的雄性生殖功能,性能优于甲福明,并且在很大程度上独立于减肥.
科学领域:
- 内分泌学 在内分泌学.
- 生殖生物学 生殖生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 2型糖尿病 (T2DM) 与男性生殖功能障碍有关.
- 氧化应激,荷尔蒙失衡和丸损伤是导致这种功能障碍的关键因素.
研究的目的:
- 评估双GIP/GLP-1受体激动剂蒂尔泽帕提德在改善糖尿病引起的男性生殖功能障碍方面的疗效.
- 为了在老鼠模型中比较蒂尔泽帕提德与甲胺的作用.
主要方法:
- 60只雄性Wistar大鼠被分为对照组,糖尿病组,治疗了蒂泽帕提德的糖尿病组,治疗了甲胺的糖尿病组和双人食的糖尿病组.
- 糖尿病是通过高脂肪饮食和 estreptozotocin 诱导的;治疗持续了八周.
- 评估了代谢,激素,精子,氧化应激,组织学和基因表达参数.
主要成果:
- 糖尿病老鼠表现出高血糖,胰岛素抵抗,减少生殖荷尔蒙,降低精子质量,增加氧化应激.
- 提尔泽帕提德改善了葡萄糖平衡,恢复了和淋巴激素水平,并通过Nrf2/Keap1通路激活增强了抗氧化防御.
- 蒂尔泽帕提德使类固醇基因表达正常化,保留丸组织结构,并减少亡,其效果优于甲福明,并且在很大程度上与体重无关.
结论:
- 蒂尔泽帕提德有效地改善了与糖尿病相关的老鼠男性生殖功能障碍.
- 药物通过协调的代谢,抗氧化和类固醇生成机制起作用.
- 蒂尔泽帕提德为T2DM相关的男性不孕症提供了一个有前途的治疗策略.
更多相关视频
03:02Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
415
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
4.0K
相关概念视频
01:23Infertility in Males
620
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
620
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
739
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
739
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
316
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
316